Scientists Find Gut Bacteria That May Help Treat Lupus

For people battling lupus, a discovery at UT Health San Antonio offers something rare: real hope for better treatment without the harsh side effects of current medications.

Scientists found that a beneficial bacterium called Faecalibacterium prausnitzii is missing in the guts of lupus patients. When they gave this bacteria to animals with lupus-like symptoms, disease markers dropped dramatically.

"This is the first time in lupus research that we have identified a bacterium that is depleted and when returned, it helps," said Dr. Laurence Morel, who led the study published in Nature Communications.

Lupus affects roughly 1.5 million Americans, causing the immune system to attack healthy tissues throughout the body. Right now, doctors can only manage symptoms with powerful immunosuppressants like steroids, which come with their own problems including weight gain, heart issues, and increased infection risk.

The research team discovered that F. prausnitzii plays a crucial role in keeping the gut healthy by helping digest dietary fiber and producing butyrate, a fatty acid that reduces inflammation. Without enough of this bacteria, the protective gut barrier breaks down and inflammation increases throughout the body.

When researchers reintroduced the bacterium to lupus models, they saw improvements not just in immune regulation but also in kidney and spleen health. The bacteria appears to work by redirecting the gut microbiome to digest more fiber and less of the protective mucin layer, promoting overall gut wellness.

Dr. Yong Ge, assistant professor on the study, called it exciting that "a single probiotic strain could do such big things."

Why This Inspires

This research represents a potential shift from just managing symptoms to addressing one of lupus's root causes. For patients who've spent years visiting different doctors seeking relief, a probiotic-based treatment could offer benefits without the serious side effects that make current medications so difficult to tolerate.

The next phase will explore which specific metabolites provide immune protection and how different dietary carbohydrates interact with the microbiome to affect health outcomes. While F. prausnitzii isn't available in stores yet (it's oxygen-sensitive and challenging to keep alive), understanding its role opens doors to new therapeutic approaches.

For a disease with no cure, finding a naturally occurring bacterium that helps restore balance feels like a light switching on in a dark room.